Inventor · disambiguated record
Matthias Beat Wittwer
Also filed as: WITTWER MATTHIAS BEAT
14 granted patents·8 pending applications·26 citations·filing 2014–2024
88Inventor score
Top patents by PatentIndex Score
22 records- 0192US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 0285US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0384US10526314B2Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereofBAYER AG·Filed 2017·Granted Jan 7, 2020·3 cites·6 claims
- 0484US10472348B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Nov 12, 2019·3 cites·12 claims
- 0579US10525041B2Fluoroalkyl-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jan 7, 2020·3 cites·13 claims
- 0676US10815205B2Amide-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 27, 2020·2 cites·13 claims
- 0774US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 0872US10927109B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2017·Granted Feb 23, 2021·1 cites·19 claims
- 0970US11091463B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2019·Granted Aug 17, 2021·0 cites·9 claims
- 1067US2024383904A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1164US2019144423A1Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1262US2025059185A1Bicyclic heterocyclic compounds useful as monoacylglycerol lipase inhibitorsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1361US2025099448A1Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1459US11472803B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2021·Granted Oct 18, 2022·0 cites·3 claims
- 1551US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1648US11149023B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Oct 19, 2021·0 cites·11 claims
- 1746US10927098B2Hydroxyalkyl-substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Feb 23, 2021·0 cites·11 claims
- 1844US11298367B2Prodrugs of substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Apr 12, 2022·0 cites·12 claims
- 1944US2016221965A1Disubstituted trifluoromethyl pyrimidinones and their useBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2043US2016237059A1Heterocyclic substituted trifluoromethyl pyrimidinones and their useBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2142US11173151B2Substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Nov 16, 2021·0 cites·13 claims
- 2239US2019119251A1Amide-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Beat Wittwer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →